# v5.2 Continuous Refinement Policy

Status: **continuously modifiable research/test strategy with governed promotion**  
Baseline milestone: `v52-batch7-final-refinement-1`  
Policy: `v52-continuous-refinement-20260909-1`

## Policy change

This policy supersedes the previous Batch 7 final-freeze rule.

Batch 7 closes the original v5.2 refinement sequence and preserves a reproducible baseline. It does **not** freeze strategy development. v5.2 may continue to evolve whenever a reasonable research, diagnostic, robustness, execution, or market-structure hypothesis warrants investigation.

The v5.1 incumbent remains authoritative unless a separate governed promotion changes that authority. Existing research/test-only reachability, paper-only operation, signing/submission restrictions, and live-money authority restrictions remain unchanged by this policy.

## Continuous modification

The v5.2 strategy may be modified continuously. A modification may be proposed, implemented, and paper-tested based on any reasonable evidence or hypothesis, including:

- new forward evidence;
- historical or backtest findings that are evaluated with appropriate leakage/overfitting controls;
- robustness or sensitivity findings;
- implementation, execution, latency, or data-quality diagnostics;
- structural market observations;
- failure analysis or regression findings;
- opportunity-cost analysis;
- simplification, risk-reduction, or measurement improvements;
- new hypotheses that can be tested without weakening safety or authority boundaries.

**New forward evidence is not a prerequisite for proposing, implementing, or paper-testing a strategy modification.**

Forward evidence remains valuable for validation and promotion, but the absence of new forward evidence must not block legitimate strategy research or refinement.

## Continuous-refinement operating loop

v5.2 development follows an ongoing loop:

`observe -> hypothesize -> modify -> paper-test -> regression/robustness evaluation -> promote, retain, or revert -> repeat`

There is no permanent strategy freeze after Batch 7 and no requirement that strategy development stop while prospective evidence accumulates.

## Change discipline

Every material strategy modification must remain auditable and must:

1. document the hypothesis, rationale, and expected effect;
2. be versioned and diffable so the exact prior strategy can be reconstructed;
3. preserve a rollback path;
4. run the applicable regression, robustness, execution, and safety tests before promotion;
5. distinguish research/test behavior from authoritative strategy behavior;
6. record whether the candidate was promoted, retained for further study, superseded, or reverted;
7. avoid silently changing strategy authority, signing, submission, or live-money permissions;
8. avoid weakening safety controls merely to create more trades or improve reported performance.

## Promotion standard

Continuous modification does **not** mean automatic promotion.

A candidate may be developed and tested at any time, but promotion into an authoritative strategy must still be supported by the repository's applicable validation, regression, robustness, governance, and safety criteria. Forward evidence may strengthen or be required by a specific promotion gate when that gate is independently justified, but **forward evidence is not a universal prerequisite for modifying or testing the strategy**.

The system should prefer evidence-weighted iteration over either permanent freezing or uncontrolled retuning.

## Reproducibility

Freeze **snapshots**, not strategy evolution.

Each promoted or otherwise decision-relevant strategy state should be immutable or reconstructable with its code/configuration version, evidence basis, test results, and promotion/reversion decision. This preserves point-in-time auditability without preventing continued improvement.

Batch 7 therefore remains a named baseline milestone for comparison, not the terminal v5.2 strategy state.

## Existing Batch 7 refinements retained

The Batch 7 baseline continues to include:

1. state hysteresis / anti-flapping;
2. signal expiration and continuation epochs;
3. velocity-sensitive quote freshness;
4. exit-capacity stress testing;
5. flow-to-price response;
6. portfolio-level opportunity competition;
7. confidence, freshness, and provenance;
8. time-to-alpha-loss measurement.

Future modifications may refine, replace, extend, or remove these mechanisms when the change is explicitly documented and passes the applicable evaluation and safety gates.

## Safety and authority constraints preserved

This policy change does **not** by itself:

- raise the `>40%` chase observe-only boundary;
- loosen exact two-sided quote or exact sell-route requirements;
- permit first-slot Pump.fun sniping;
- increase allocation merely because a token is accelerating;
- lower evidence standards to force trades;
- give an informational/research model independent trading authority;
- permit averaging down;
- weaken structural exit hard stops;
- enable signing;
- enable transaction submission;
- enable live-money authority.

The absolute immediate-copy hard ceiling remains **20 seconds** unless a future, separately justified strategy modification explicitly changes that rule through the normal governed refinement process. Dynamic quote freshness remains an additional tighter requirement while that baseline is active.

## Certification expectations

Certification should prove the exact strategy version actually under test rather than prove that strategy development has stopped. At minimum, the applicable certification evidence must continue to establish:

- exact strategy/version fingerprint;
- authoritative-versus-challenger authority state;
- research/test versus production reachability;
- paper-only status where required;
- signing status;
- transaction-submission status;
- live-money authority status;
- execution-evidence requirements for the tested version;
- structural exit controls for the tested version;
- latency and chase controls for the tested version;
- regression and rollback traceability;
- absence of unrecorded or silent strategy mutation.

**Batch 7 is a baseline milestone, not a freeze. v5.2 strategy development is intentionally continuous.**
